Robert Califf
Showing 1–3 of 3 transcripts.
- Milken Institute54 min
The Future of Biomedical Research and Innovation | Future of Health Summit 2025
Esther Krofah, Robert Califf, Julie Gerberding, Sharmila Makhija, Elias Zerhouni
A comprehensive review of the U.S. biomedical ecosystem reveals that the nation's seven-pillar research framework is currently threatened by a convergence of reduced federal funding, immigration restrictions, and ideological pressures on universities, all while global competitors like China and Singapore accelerate their own centralized health strategies. Despite possessing a premier research engine, the United States suffers from a critical implementation gap where $5.4 trillion in annual healthcare spending fails to address fundamental issues like low life expectancy, high medical bankruptcy, and a severe erosion of public trust in scientific institutions. Strategic recommendations now urge a shift toward a unified national life sciences strategy that leverages federated data infrastructure, aligns financial incentives with preventive care, and mobilizes political and voter engagement to restore the country's competitive edge in global innovation.
- Milken Institute20 min
A Conversation with FDA Commissioner Robert Califf | Future of Health Summit 2024
Commissioner Califf reflects on his tenure managing the Abbott infant formula recall and reorganizing the FDA Food Program, emphasizing that the agency faces a healthcare delivery crisis rather than an innovation deficit despite the U.S. global leadership in scientific advancement. He advocates for shifting regulatory focus from pre-approval trials to post-market pragmatic studies and new frameworks for AI decision support to address systemic biases and monitor uncontrolled algorithmic drift in clinical environments. Califf concludes by defining essential traits for future leadership, prioritizing executive listening skills and a commitment to high-quality evidence generation while maintaining a strict separation between science-based product decisions and politically influenced policy mandates.
- Milken Institute22 min
A Conversation with FDA Commissioner Robert Califf | Future of Health Summit 2023
Robert Califf, Conrad Kiechel, Esther Krofah
FDA Commissioner Robert Califf highlighted a critical gap in U.S. health outcomes, noting that despite high spending, life expectancy has fallen to 76.4 years while fragmented post-market evidence systems fail to answer key treatment questions. To address this, Califf proposed a unified ecosystem involving the CMS, NIH, and FDA to leverage real-world data and AI for generating rigorous post-approval evidence while incentivizing clinicians to participate in large-scale research. Additionally, the agency plans to combat persistent public distrust and medical misinformation through plain-language communication and a broad coalition of academic, industry, and community partners.